n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with Cancer of Eye in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacin, F; Bonafous, J; Chossat, F; D'Incan, M; Kemeny, JL; Mestas, D; Moins, N; Sillaire-Houtmann, I; Veyre, A | 1 |
1 trial(s) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and Cancer of Eye
Article | Year |
---|---|
[Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
Topics: Benzamides; Choroid Neoplasms; Ciliary Body; Conjunctival Neoplasms; Diagnosis, Differential; Eye Neoplasms; Female; Humans; Iodine Radioisotopes; Liver Neoplasms; Male; Melanoma; Ophthalmoscopy; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Skin Neoplasms; Tomography, X-Ray Computed; Ultrasonography; Uveal Neoplasms | 2004 |